Cartilage-targeting drug delivery: can electrostatic interactions help?

Current intra-articular drug delivery methods do not guarantee sufficient drug penetration into cartilage tissue to reach cell and matrix targets at the concentrations necessary to elicit the desired biological response. Here, we provide our perspective on the utilization of charge–charge (electrostatic) interactions to enhance drug penetration and transport into cartilage, and to enable sustained binding of drugs within the tissue's highly negatively charged extracellular matrix. By coupling drugs to positively charged nanocarriers that have optimal size and charge, cartilage can be converted from a drug barrier into a drug reservoir for sustained intra-tissue delivery. Alternatively, a wide variety of drugs themselves can be made cartilage-penetrating by functionalizing them with specialized positively charged protein domains. Finally, we emphasize that appropriate animal models, with cartilage thickness similar to that of humans, must be used for the study of drug transport and retention in cartilage.

[1]  Sarah Onuora Osteoarthritis: Sprifermin shows cartilage-protective effects in knee OA , 2014, Nature Reviews Rheumatology.

[2]  A. Maroudas,et al.  The distribution of serum albumin in human normal and degenerate articular cartilage. , 1976, Biochimica et biophysica acta.

[3]  S. Jacobsen,et al.  Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders. , 2008, Journal of pharmaceutical sciences.

[4]  David L Kaplan,et al.  Silk constructs for delivery of musculoskeletal therapeutics. , 2012, Advanced drug delivery reviews.

[5]  R. Meyboom,et al.  Sustained intra-articular release of celecoxib from in situ forming gels made of acetyl-capped PCLA-PEG-PCLA triblock copolymers in horses. , 2015, Biomaterials.

[6]  R. Copeland,et al.  Aggrecan Protects Cartilage Collagen from Proteolytic Cleavage* , 2003, Journal of Biological Chemistry.

[7]  Richard T. Lee,et al.  Targeted Delivery to Cartilage Is Critical for In Vivo Efficacy of Insulin‐like Growth Factor 1 in a Rat Model of Osteoarthritis , 2014, Arthritis & rheumatology.

[8]  M-P. Hellio Le Graverand-Gastineau OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed? , 2009 .

[9]  D. Caborn,et al.  Articular Cartilage Changes Seen With Magnetic Resonance Imaging-Detected Bone Bruises Associated With Acute Anterior Cruciate Ligament Rupture , 1998, The American journal of sports medicine.

[10]  V. Soccol,et al.  Effect of pegylated phosphatidylserine-containing liposomes in experimental chronic arthritis , 2015, BMC Pharmacology and Toxicology.

[11]  B Schoeberl,et al.  Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: relevance to post-traumatic osteoarthritis. , 2014, Osteoarthritis and cartilage.

[12]  J. Kim,et al.  Intra-articular delivery of kartogenin-conjugated chitosan nano/microparticles for cartilage regeneration. , 2014, Biomaterials.

[13]  T. Matsushita,et al.  Intra-articular administration of gelatin hydrogels incorporating rapamycin-micelles reduces the development of experimental osteoarthritis in a murine model. , 2014, Biomaterials.

[14]  T. Quinn,et al.  Dynamic compression augments interstitial transport of a glucose-like solute in articular cartilage. , 2006, Biophysical journal.

[15]  P. Hammond,et al.  Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term. , 2015, Osteoarthritis and cartilage.

[16]  F. Dellaert,et al.  Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial , 2015, BMC Musculoskeletal Disorders.

[17]  Seth L. Sherman,et al.  A Review of Translational Animal Models for Knee Osteoarthritis , 2012, Arthritis.

[18]  P. R. Weeren,et al.  Of Mice, Men and Elephants: The Relation between Articular Cartilage Thickness and Body Mass , 2013, PloS one.

[19]  M. Windbergs,et al.  The effect of polymer size and charge of molecules on permeation through synovial membrane and accumulation in hyaline articular cartilage. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  D. Hunter,et al.  Emerging drugs for osteoarthritis , 2011, Expert opinion on emerging drugs.

[21]  A. Grodzinsky,et al.  Transport of anti-IL-6 antigen binding fragments into cartilage and the effects of injury. , 2013, Archives of biochemistry and biophysics.

[22]  M. A. R. Freeman,et al.  Adult Articular Cartilage , 1973 .

[23]  Guizhong Wu,et al.  Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model. , 2013, International journal of pharmaceutics.

[24]  L. Setton,et al.  Progress in intra-articular therapy , 2014, Nature Reviews Rheumatology.

[25]  Y. Pi,et al.  Intra-articular delivery of anti-Hif-2α siRNA by chondrocyte-homing nanoparticles to prevent cartilage degeneration in arthritic mice , 2015, Gene Therapy.

[26]  E. Hæggström,et al.  Delivering Agents Locally into Articular Cartilage by Intense MHz Ultrasound , 2015, Ultrasound in medicine & biology.

[27]  L. Bonassar,et al.  The effect of dynamic compression on the response of articular cartilage to insulin‐like growth factor‐I , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[28]  C. Little,et al.  On the predictive utility of animal models of osteoarthritis , 2015, Arthritis Research & Therapy.

[29]  P. Patwari,et al.  Individual cartilage aggrecan macromolecules and their constituent glycosaminoglycans visualized via atomic force microscopy. , 2003, Journal of structural biology.

[30]  D. Heinegård,et al.  The role of the cartilage matrix in osteoarthritis , 2011, Nature Reviews Rheumatology.

[31]  D. Loeuille,et al.  Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. , 2009, Arthritis and rheumatism.

[32]  N. Bottini,et al.  Polyethylene-glycol-modified single-walled carbon nanotubes for intra-articular delivery to chondrocytes. , 2014, ACS nano.

[33]  D. R. Coombe Biological implications of glycosaminoglycan interactions with haemopoietic cytokines , 2008, Immunology and cell biology.

[34]  M. Hellio Le Graverand-Gastineau,et al.  OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed? , 2009, Osteoarthritis and cartilage.

[35]  A. Grodzinsky,et al.  A rabbit model demonstrates the influence of cartilage thickness on intra‐articular drug delivery and retention within cartilage , 2015, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[36]  L. Setton,et al.  Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic. , 2007, Arthritis and rheumatism.

[37]  Nicole Gerwin,et al.  Intraarticular drug delivery in osteoarthritis. , 2006, Advanced drug delivery reviews.

[38]  A. Grodzinsky,et al.  A molecular model of proteoglycan-associated electrostatic forces in cartilage mechanics. , 1995, Journal of biomechanical engineering.

[39]  D. Heinegård,et al.  The C-terminal Peptide of Chondroadherin Modulates Cellular Activity by Selectively Binding to Heparan Sulfate Chains* , 2012, The Journal of Biological Chemistry.

[40]  T. Kamarul,et al.  Correction: Chondrocyte density, proteoglycan content and gene expressions from native cartilage are species specific and not dependent on cartilage thickness: a comparative analysis between rat, rabbit and goat , 2013, BMC Veterinary Research.

[41]  F. Dell’Accio,et al.  Human single-chain variable fragment that specifically targets arthritic cartilage , 2010, Arthritis and rheumatism.

[42]  David J. Hunter,et al.  Pharmacologic therapy for osteoarthritis—the era of disease modification , 2011, Nature Reviews Rheumatology.

[43]  D. Heinegård,et al.  The glycosaminoglycan-binding domain of PRELP acts as a cell type–specific NF-κB inhibitor that impairs osteoclastogenesis , 2009, The Journal of cell biology.

[44]  D. Hunter,et al.  Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis , 2010, BMC musculoskeletal disorders.

[45]  D. Weitz,et al.  On-demand drug delivery from self-assembled nanofibrous gels: a new approach for treatment of proteolytic disease. , 2011, Journal of biomedical materials research. Part A.

[46]  byBrooke LaBranche Osteoarthritis ? an untreatable disease ? , 2017 .

[47]  C. Evans Drug delivery to chondrocytes. , 2016, Osteoarthritis and cartilage.

[48]  D. Eyre,et al.  Articular cartilage collagen: an irreplaceable framework? , 2006, European cells & materials.

[49]  Alan J. Grodzinsky,et al.  Fields, Forces, and Flows in Biological Systems , 2011 .

[50]  D. Serteyn,et al.  Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis. , 2015, International journal of pharmaceutics.

[51]  M. Morgen,et al.  Nanoparticles for Improved Local Retention after Intra-Articular Injection into the Knee Joint , 2012, Pharmaceutical Research.

[52]  B. Giraudeau,et al.  Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study. , 2005, The Journal of rheumatology.

[53]  Lixin Yang,et al.  Biodegradable electrospun fibers for drug delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[54]  W. Garrett,et al.  Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). , 2012, Osteoarthritis and cartilage.

[55]  F. Guilak,et al.  Sustained intra-articular delivery of IL-1RA from a thermally-responsive elastin-like polypeptide as a therapy for post-traumatic arthritis. , 2015, European cells & materials.

[56]  D. Frisbie,et al.  A comparative study of articular cartilage thickness in the stifle of animal species used in human pre-clinical studies compared to articular cartilage thickness in the human knee , 2006, Veterinary and Comparative Orthopaedics and Traumatology.

[57]  A. Grodzinsky,et al.  Electrostatic interactions enable rapid penetration, enhanced uptake and retention of intra‐articular injected avidin in rat knee joints , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[58]  D. Hunter,et al.  Post-traumatic osteoarthritis: from mouse models to clinical trials , 2013, Nature Reviews Rheumatology.

[59]  A. Grodzinsky,et al.  Transport and equilibrium uptake of a peptide inhibitor of PACE4 into articular cartilage is dominated by electrostatic interactions. , 2010, Archives of biochemistry and biophysics.

[60]  M. Bawendi,et al.  Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis. , 2014, Biomaterials.

[61]  A. Maroudas,et al.  Transport of solutes through cartilage: permeability to large molecules. , 1976, Journal of anatomy.

[62]  C. Frank,et al.  Dexamethasone inhibits inflammation and cartilage damage in a new model of post‐traumatic osteoarthritis , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[63]  D. Hunter,et al.  The great debate: Should Osteoarthritis Research Focus on "Mice" or "Men"? , 2016, Osteoarthritis and cartilage.

[64]  A. Grodzinsky,et al.  Adenovirus-mediated gene transfer of glutamine: fructose-6-phosphate amidotransferase antagonizes the effects of interleukin-1beta on rat chondrocytes. , 2004, Osteoarthritis and cartilage.

[65]  B. Hall,et al.  Cartilage Molecular Aspects , 1991 .

[66]  Hugh C Burry,et al.  Adult Articular Cartilage , 1974 .

[67]  Richard T. Lee,et al.  Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate. , 2010, Arthritis and rheumatism.

[68]  W. Mark Saltzman,et al.  A holistic approach to targeting disease with polymeric nanoparticles , 2015, Nature Reviews Drug Discovery.

[69]  K. Youcef-Toumi,et al.  High-bandwidth AFM-based rheology reveals that cartilage is most sensitive to high loading rates at early stages of impairment. , 2013, Biophysical journal.

[70]  Y. Vugmeyster,et al.  Disposition of Human Recombinant Lubricin in Naive Rats and in a Rat Model of Post-traumatic Arthritis After Intra-articular or Intravenous Administration , 2012, The AAPS Journal.

[71]  C. Jorgensen,et al.  siRNA-based therapeutic approaches for rheumatic diseases , 2013, Nature Reviews Rheumatology.

[72]  Stanley B. Cohen,et al.  A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee , 2011, Arthritis research & therapy.

[73]  K. Johnson A stem cell-based approach to cartilage repair , 2013 .

[74]  T. Koob,et al.  Early changes in material properties of rabbit articular cartilage after meniscectomy , 1983, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[75]  Shouan Zhu,et al.  Inhibition of Rac1 activity by controlled release of NSC23766 from chitosan microspheres effectively ameliorates osteoarthritis development in vivo , 2013, Annals of the rheumatic diseases.

[76]  A. Maroudas,et al.  Influence of cyclic loading on the nutrition of articular cartilage. , 1990, Annals of the rheumatic diseases.

[77]  D. Hunter,et al.  An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial. , 2015, The Journal of bone and joint surgery. American volume.

[78]  J. Hubbell,et al.  Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. , 2008, Nature materials.

[79]  Yang Wang,et al.  Intra‐articular dexamethasone to inhibit the development of post‐traumatic osteoarthritis , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[80]  James A. Martin,et al.  Post‐traumatic osteoarthritis: Improved understanding and opportunities for early intervention , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.